195 related articles for article (PubMed ID: 15562909)
21. Activity of sitafloxacin against extracellular and intracellular Staphylococcus aureus in vitro and in vivo: comparison with levofloxacin and moxifloxacin.
Shi G; Chen X; Wang H; Wang S; Guo X; Zhang X
J Antibiot (Tokyo); 2012 May; 65(5):229-36. PubMed ID: 22334239
[TBL] [Abstract][Full Text] [Related]
22. Clinical efficacy and correlation of clinical outcomes with in vitro susceptibility for anaerobic bacteria in patients with complicated intra-abdominal infections treated with moxifloxacin.
Goldstein EJ; Solomkin JS; Citron DM; Alder JD
Clin Infect Dis; 2011 Dec; 53(11):1074-80. PubMed ID: 21998288
[TBL] [Abstract][Full Text] [Related]
23. Prevention of the selection of resistant Staphylococcus aureus by moxifloxacin plus doxycycline in an in vitro dynamic model: an additive effect of the combination.
Firsov AA; Vostrov SN; Lubenko IY; Portnoy YA; Zinner SH
Int J Antimicrob Agents; 2004 May; 23(5):451-6. PubMed ID: 15120722
[TBL] [Abstract][Full Text] [Related]
24. Antibiotic resistance in human chronic periodontitis microbiota.
Rams TE; Degener JE; van Winkelhoff AJ
J Periodontol; 2014 Jan; 85(1):160-9. PubMed ID: 23688097
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of amoxicillin and metronidazole combination for the management of generalized aggressive periodontitis.
Yek EC; Cintan S; Topcuoglu N; Kulekci G; Issever H; Kantarci A
J Periodontol; 2010 Jul; 81(7):964-74. PubMed ID: 20214441
[TBL] [Abstract][Full Text] [Related]
26. [Pharmacokinetic/pharmacodynamic analysis of antibiotic therapy in dentistry and stomatology].
Isla A; Canut A; Rodríguez-Gascón A; Labora A; Ardanza-Trevijano B; Solinís MA; Pedraz JL
Enferm Infecc Microbiol Clin; 2005 Mar; 23(3):116-21. PubMed ID: 15757581
[TBL] [Abstract][Full Text] [Related]
27. Moxifloxacin as an adjunctive antibiotic in the treatment of severe chronic periodontitis.
Guentsch A; Jentsch H; Pfister W; Hoffmann T; Eick S
J Periodontol; 2008 Oct; 79(10):1894-903. PubMed ID: 18834244
[TBL] [Abstract][Full Text] [Related]
28. Microbiological and clinical results of metronidazole plus amoxicillin therapy in Actinobacillus actinomycetemcomitans-associated periodontitis.
van Winkelhoff AJ; Tijhof CJ; de Graaff J
J Periodontol; 1992 Jan; 63(1):52-7. PubMed ID: 1313103
[TBL] [Abstract][Full Text] [Related]
29. Strong antibacterial effect of miswak against oral microorganisms associated with periodontitis and caries.
Sofrata AH; Claesson RL; Lingström PK; Gustafsson AK
J Periodontol; 2008 Aug; 79(8):1474-9. PubMed ID: 18672998
[TBL] [Abstract][Full Text] [Related]
30. In vitro activity of tetracyclines, macrolides, quinolones, clindamycin and metronidazole against periodontopathic bacteria.
Miyake Y; Tsuruda K; Okuda K; Widowati ; Iwamoto Y; Suginaka H
J Periodontal Res; 1995 Jul; 30(4):290-3. PubMed ID: 7562327
[TBL] [Abstract][Full Text] [Related]
31. Clindamycin promotes phagocytosis and intracellular killing of periodontopathogenic bacteria by crevicular granulocytes: an in vitro study.
Eick S; Pfister W; Fiedler D; Straube E
J Antimicrob Chemother; 2000 Oct; 46(4):583-8. PubMed ID: 11020256
[TBL] [Abstract][Full Text] [Related]
32. In vitro invasion and survival of Porphyromonas gingivalis in gingival fibroblasts; role of the capsule.
Irshad M; van der Reijden WA; Crielaard W; Laine ML
Arch Immunol Ther Exp (Warsz); 2012 Dec; 60(6):469-76. PubMed ID: 22949096
[TBL] [Abstract][Full Text] [Related]
33. Microbiological response to mechanical treatment in combination with adjunctive therapy. A review of the literature.
Bollen CM; Quirynen M
J Periodontol; 1996 Nov; 67(11):1143-58. PubMed ID: 8959563
[TBL] [Abstract][Full Text] [Related]
34. In vitro interactions of LytA, the major pneumococcal autolysin, with two bacteriophage lytic enzymes (Cpl-1 and Pal), cefotaxime and moxifloxacin against antibiotic-susceptible and -resistant Streptococcus pneumoniae strains.
Rodríguez-Cerrato V; García P; Del Prado G; García E; Gracia M; Huelves L; Ponte C; López R; Soriano F
J Antimicrob Chemother; 2007 Nov; 60(5):1159-62. PubMed ID: 17827138
[TBL] [Abstract][Full Text] [Related]
35. Microbiological changes with the use of locally delivered doxycycline in the periodontal treatment of smokers.
Machion L; Andia DC; Saito D; Klein MI; Gonçalves RB; Casati MZ; Nociti FH; Sallum EA
J Periodontol; 2004 Dec; 75(12):1600-4. PubMed ID: 15732860
[TBL] [Abstract][Full Text] [Related]
36. Antibacterial activity of moxifloxacin on bacteria associated with periodontitis within a biofilm.
Tsaousoglou P; Nietzsche S; Cachovan G; Sculean A; Eick S
J Med Microbiol; 2014 Feb; 63(Pt 2):284-292. PubMed ID: 24217128
[TBL] [Abstract][Full Text] [Related]
37. Antimicrobial susceptibility variation of 50 anaerobic periopathogens in aggressive periodontitis: an interindividual variability study.
Lakhssassi N; Elhajoui N; Lodter JP; Pineill JL; Sixou M
Oral Microbiol Immunol; 2005 Aug; 20(4):244-52. PubMed ID: 15943770
[TBL] [Abstract][Full Text] [Related]
38. Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis subgingival presence, species-specific serum immunoglobulin G antibody levels, and periodontitis disease recurrence.
Rams TE; Listgarten MA; Slots J
J Periodontal Res; 2006 Jun; 41(3):228-34. PubMed ID: 16677293
[TBL] [Abstract][Full Text] [Related]
39. Antibacterial activity of moxifloxacin against periodontal anaerobic pathogens involved in systemic infections.
Milazzo I; Blandino G; Musumeci R; Nicoletti G; Lo Bue AM; Speciale A
Int J Antimicrob Agents; 2002 Dec; 20(6):451-6. PubMed ID: 12458140
[TBL] [Abstract][Full Text] [Related]
40. [Bacteriologic investigation of periodontal infections].
Barna Z; Keglevich T; Gera I
Fogorv Sz; 2001 Jun; 94(3):97-100. PubMed ID: 11480243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
